A Field Full of Momentum: Mid-Year Progress and the Road Ahead in Follicular Lymphoma Research
The FLF’s Chief Medical Officer Dr Mitchell Smith, reviews major developments in follicular lymphoma research during the first half of 2026.
Bispecific Antibodies: Harnessing the Immune System to treat Follicular Lymphoma
Being told you have cancer but do not need treatment straight away can feel confusing and frightening. Many people with follicular lymphoma are surprised when their healthcare team recommends “watch and wait”, also known as active monitoring.
Coping with the Down Days
Fear, anxiety and uncertainty are common experiences for people living with follicular lymphoma. In this article, blood cancer specialist psychologist Surabhi Chaturvedi and FL patient Claire Hucker share practical strategies for managing difficult emotions, coping with uncertainty and navigating the down days that can come with an FL diagnosis.
Why Aren’t We Treating It? Understanding Watch and Wait
Being told you have cancer but do not need treatment straight away can feel confusing and frightening. Many people with follicular lymphoma are surprised when their healthcare team recommends “watch and wait”, also known as active monitoring.
Watch and Wait: What I Wish I’d Known at the Beginning
People living with follicular lymphoma (FL) have always played a vital role in shaping our work; bringing lived experience to shape research, education and patient support.
The Hidden Power of Every Patient Story
FL Voices, is the Follicular Lymphoma Foundation’s flexible patient involvement network. Share your experiences, shape research, and make a difference.
The FLF Super Supporters: Six Years of Impact and Community
People living with follicular lymphoma (FL) have always played a vital role in shaping our work; bringing lived experience to shape research, education and patient support.
Could some people with Follicular Lymphoma Be Cured? New evidence sparks careful optimism
New long-term research is raising one of the most important, and sensitive, questions in follicular lymphoma: could a subset of patients already be cured?
Busting the myth – “trials are for when nothing else works”
Our third myth busting article of the series, where we breakdown the common myths around clinical trials. This article looks at how clinical trials happen at every stage of FL.
Busting the myth: you’ll be a Guinea Pig trying something untested
Our final myth busting article of the series, where we breakdown the common myths around clinical trials with this article focusing on safety at each trial phase.